Of the 48 deals in November, only 4 appear to have classic “VCs” as lead investors. That’s a surprisingly low ratio.
Deal volume in November was up 20% vs. October, even with Thanksgiving in the mix. Total deal value was up ~$100M (from $1.79B to $1.88B).
Series B Deals
Summary Stats
Data for Series B deals done worldwide (ex-China) where amount raised is greater than $5M and the company is not focused on therapeutics.